This video highlights 2-year results of a phase II study evaluating aggressive adjuvant chemoradiation dose de-escalation in HPV-positive oropharynx squamous cell carcinoma.
Daniel J. Ma, MD
Advertisement
Articles by Daniel J. Ma, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Navigating CAR T-Cell Therapy Use as a “Team Sport” in Multiple Myeloma
2
Concomitant COVID-19 Vaccination Tied to Improved OS with Immunotherapy
3
FDA Approves Dato-DXd for Metastatic Triple-Negative Breast Cancer
4
FDA Approves FoundationOne CDx for Tepotinib in MET+ NSCLC
5